Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.
E DreesenT Van StappenV BalletM PeetersG CompernolleS TopsK Van SteenG Van AsscheMarc FerranteS VermeireAnn GilsPublished in: Alimentary pharmacology & therapeutics (2017)
Antibodies towards infliximab can guide clinical decision-making on treatment intensification.
Keyphrases